Peptide-based adsorbers like Globaffin and Coraffin represent a novel therapeutic option for immunoadsorption in patients with dilated cardiomyopathy and autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for peptide-based immunoadsorption in autoimmune diseases and idiopathic dilated cardiomyopathy; should not yet change practice.
Rönspeck et al. (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: